Veracyte | VCYT - Interest Expense On Debt


Veracyte reported $2K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Agenus USD 16.02M 2.85M Dec/2025
Agilent USD 25M 0 Mar/2026
Anika Therapeutics 179.39M 556.84M Mar/2026
Arrowhead Research USD 22.5M 811K Dec/2025
Bruker USD 8.1M 11.9M Dec/2025
Heron Therapeutics USD 600K 100K Dec/2024
Illumina USD 26M 1000K Dec/2025
Intrexon USD 2K 5K Jun/2024
Karyopharm Therapeutics USD 12.62M 1.24M Dec/2025
Laboratory Of America USD 55.1M 100K Mar/2026
Ligand Pharmaceuticals USD 1.78M 875K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
Rigel Pharmaceuticals USD 2.06M 31K Sep/2024
Roche Holding CHF 304M 7.5M Jun/2025
Sangamo BioSciences 97.56M 11.39M Jun/2025
Siemens EUR 435M 1000K Dec/2025
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Thermo Fisher Scientific USD 354M 11M Mar/2026
Veracyte USD 2K 1000 Dec/2023
Waters USD 42M 33.38M Mar/2026